The NRG Oncology Podcast co-hosts interview Dr. Anuja Jhingran to discuss the results of NRG-RTOG/GOG 0724 for cervical cancer in honor of Cervical Cancer Awareness Month.

Our NRG Oncology Podcast co-hosts interview Dr. Corey Langer on the ins-and-outs of medical oncology, the NRG Oncology Medical Oncology Committee, the evolution of lung cancer trials, and having conversations with patients regarding treatment.

The NRG Oncology Podcast co-hosts sit with Dr. Anna Brown to discuss the many ways to collaborate with the American Medical Association (AMA), policy and advocacy in action on the Hill, and addressing clinical trial barriers.

DISCLAIMER: The views expressed in this podcast are reflective of Dr. Brown's experiences in nationally elected roles with the AMA but do not represent official opinions of the American Medical Association.

RESOURCES:

AMA's Website for Fixing Prior Authorization

Drs. Chun and Henke sit down with Dr. Stephen Lai, the NRG Oncology Surgical Oncology Committee Chair and the PI of the NRG-HN006 study of sentinel lymph node biopsy for early stage oral cavity disease. Dr. Lai addresses how surgical oncology fits within the NRG spectrum, his very important study that is actively enrolling patients, and his advocacy and passion for improving patient language on protocol documents.

Our co-hosts interview Drs. Kristin Higgins and Dr. Sue Yom on the results of NRG-LU005 (chemo +/- atezo in limited-stage small cell lung cancer) and NRG-HN005 (de-intensified RT for Early-stage p16+ oropharyngeal cancer) presented during the 2024 ASTRO Plenary Session.

The NRG Oncology Podcast Co-hosts interview Group Chair Robert Mannel on ongoing efforts in gynecologic oncology research, a timely episode to be issued during Gynecologic Cancer Awareness Month! Dr. Mannel also touches base on the health disparities in gynecologic oncology as well as advice for early career investigators.

The NRG Podcast co-hosts interview Dr. Puneeth Iyengar on the recently presented NRG-LU002 results from ASCO 2024. NRG-LU002 studies maintenance systemic therapy versus local consolidative therapy plus maintenance systemic therapy for patients with limited-metastatic non-small cell lung cancer.

Dr. Quynh-Thu Le, one of the NRG Oncology Group Chairs, discusses the ins-and-outs and current goals of the organization.